Nyormoi O
Department of Neurology, Baylor College of Medicine, Houston, TX, USA.
Ann Neurol. 1996 Nov;40(5):701-6. doi: 10.1002/ana.410400505.
Sporadic amyotrophic lateral sclerosis is a motor neuron disease of unknown origin. Autoimmunity against voltage-gated calcium channels is one mechanism hypothesized to be the cause of the disease. In support of this hypothesis, it was previously reported that amyotrophic lateral sclerosis IgG specifically blocked the binding of 8B7 monoclonal antibody to the alpha1 subunit of voltage-gated calcium channels, suggesting overlapping epitopes of the two antibodies. It is, however, possible that the 8B7 epitope was destroyed by proteases. Data presented here show that the blocking of 8B7 binding to the alpha1 subunit by diethylaminoethyl cellulose (DEAE)-purified amyotrophic lateral sclerosis IgG was not observed with Fab fragments of amyotrophic lateral sclerosis IgG. The blocking was prevented by serine protease inhibitors. Moreover, it was reproduced by plasminogen and urokinase. These observations suggest that raised proteolytic activity in amyotrophic lateral sclerosis IgG preparations may be responsible for the blockade of 8B7 monoclonal antibody demonstrated previously. They also indicate the need to be particularly cautious when interpreting the results of incubation in amyotrophic lateral sclerosis sera or IgG preparations. Furthermore, they suggest that proteases may be partly responsible for some of the effects previously described for amyotrophic lateral sclerosis IgG. However, the proteolytic activity needs to be better defined and its possible role in amyotrophic lateral sclerosis investigated.
散发性肌萎缩侧索硬化症是一种病因不明的运动神经元疾病。针对电压门控钙通道的自身免疫是被推测为该疾病病因的一种机制。支持这一假说的是,此前有报道称肌萎缩侧索硬化症免疫球蛋白G(IgG)特异性地阻断了8B7单克隆抗体与电压门控钙通道α1亚基的结合,这表明两种抗体存在重叠表位。然而,8B7表位有可能被蛋白酶破坏。此处呈现的数据表明,用二乙氨基乙基纤维素(DEAE)纯化的肌萎缩侧索硬化症IgG可阻断8B7与α1亚基的结合,但肌萎缩侧索硬化症IgG的Fab片段却未出现这种情况。丝氨酸蛋白酶抑制剂可阻止这种阻断作用。此外,纤溶酶原和尿激酶可重现这种阻断作用。这些观察结果表明,肌萎缩侧索硬化症IgG制剂中升高的蛋白水解活性可能是先前证明的8B7单克隆抗体阻断作用的原因。它们还表明,在解释肌萎缩侧索硬化症血清或IgG制剂的孵育结果时需要格外谨慎。此外,它们提示蛋白酶可能部分导致了先前描述的肌萎缩侧索硬化症IgG的某些效应。然而,蛋白水解活性需要得到更明确的界定,并对其在肌萎缩侧索硬化症中的可能作用进行研究。